Remove Drug Delivery Remove Life Science Remove Regulation
article thumbnail

Employee Retention and Motivation Strategies for Life Science Companies — Free Onboarding Checklist Included

XTalks

Employee retention and motivation is a challenge that all life science companies face. A corporate compliance training program is a part of many onboarding programs to ensure employees are up to date with the latest rules and regulations they must adhere to while working for the company. Employee Compensation and Rewards.

article thumbnail

Agent Drug-Coated Balloon: A New Era in Coronary In-Stent Restenosis Treatment

XTalks

Drug-eluting stents (DES): DES reduce the incidence of restenosis and are coated with drugs that inhibit scar tissue growth. DCBs: DCBs, such as the Agent DCB, combine mechanical widening of the artery with drug delivery to the vessel wall to prevent cell proliferation.

Drugs 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Revolo Biotherapeutics’ Unique Approach to Developing Treatments for Autoimmune and Allergic Diseases

XTalks

Dr. Bryan began his career at Schering-Plough, engaging in formulation and drug delivery. The company’s drug product candidates ‘1104 and ‘1805 modify how monocytes and macrophages respond to antigens, potentially directing the immune system towards a more regulated, balanced response.

article thumbnail

RE-TRANSMISSION: XPhyto Appoints European Healthcare Executive to Board of Directors

The Pharma Data

CorpCann is a Norwegian-based international investment and consulting firm focused on European and North American opportunities in the life science, nutraceutical, aquaculture and energy industries. XPhyto is also pleased to announce a strategic European advisor engagement with CorpCann AS (“CorpCann”).

article thumbnail

The Philips Tack Endovascular System Optimizes the Treatment of Dissections in Patients with Critical Limb Ischemia

XTalks

The featured speakers will discuss how life science manufacturers can now save time, money and resources and increase time to market by doing away with fully customized QMS solutions — while remaining compliant with industry regulations and standards.

article thumbnail

Considerations for Neuroscience Trials with Intrathecal Delivery and Other Methods of Direct CNS Administration

XTalks

One of the biggest challenges with developing therapies to treat CNS disorders is the delivery of systemically administered investigational products (IPs) to the brain, which is limited by the blood-brain barrier. Some methods of direct CNS administration include intrathecal, intraparenchymal and intracerebroventricular (ICV) delivery.

Trials 83
article thumbnail

XPhyto Announces Business Strategy and Milestones For 2021 Innovation to Impact

The Pharma Data

As a bioscience accelerator at the leading-edge of the life science industry, XPhyto will target growth through commercialization of existing products and focused investment in impact driven innovation with the potential for extreme value creation. About XPhyto Therapeutics Corp. XPhyto Therapeutics Corp.